top of page

English News Releases

Our CEO Rob Claar talks about opportunities for global innovators in Japan's MedTech market Aug. 3, 2023

Our CEO Rob Claar talks about opportunities for global innovators in Japan's MedTech market Aug. 3, 2023

Our CEO Rob Claar talks about opportunities for global innovators in Japan's MedTech market Aug. 3, 2023

2023年8月3日

ATMKK attends 24th Brachytherapy Subcommittee Academic Conference Seminar May 24, 2022

ATMKK attends 24th Brachytherapy Subcommittee Academic Conference Seminar May 24, 2022

ATMKK attends 24th Brachytherapy Subcommittee Academic Conference Seminar May 24, 2022

2022年5月24日

Limaca Medical and HekaBio Announce Japan Partnership May 17, 2022

Limaca Medical and HekaBio Announce Japan Partnership May 17, 2022

Limaca Medical and HekaBio Announce Japan Partnership May 17, 2022

2022年5月17日

Alpha Tau Medical (DRTS) rings the bell at NASDAQ Apr. 11, 2022

Alpha Tau Medical (DRTS) rings the bell at NASDAQ Apr. 11, 2022

Alpha Tau Medical (DRTS) rings the bell at NASDAQ Apr. 11, 2022

2022年4月11日

Completion of HB-001 Open Label Study in Japan Jan. 11, 2022

Completion of HB-001 Open Label Study in Japan Jan. 11, 2022

Completion of HB-001 Open Label Study in Japan Jan. 11, 2022

2022年1月11日

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM Oct. 12, 2021

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM Oct. 12, 2021

Alpha Tau Receives FDA's Breakthrough Device Designation for the Treatment of Recurrent GBM Oct. 12, 2021

2021年10月12日

トップページへ

bottom of page